Global Ventilator Market – Analysis By Mobility (Intensive Care, Portable), Modes, Interface, End User, By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)

  • Report Id: AZR 18295
  • Published Date: June, 2020
  • No of Pages: 280
  • Format: Electronic (PDF)
  • Publisher: Azoth Analytics
  • Category:

Executive Summary

Global Ventilator Market was valued at USD 1198.54 Million in the year 2019. Escalating number of cases related to Respiratory and Lungs Diseases with growing prevalence of COPD, Strokes supported by ever growing geriatric population and companies investing heavily in incorporating advanced technology in order to offer high quality, latest technology products to hospitals and healthcare units with growing transmission of coronavirus across the world has been anticipated to infuse growth in the market for Ventilators during the forecast period of 2020-2025.
Under the Mobility segment, Intensive Care ventilators are anticipated to witness the largest market share owing to growing availability of different types of ventilators primarily made for hospital use clubbed with manufacturers collaborating with hospitals and doctors to better understand their demand and meet their requirements. Also, surging number of coronavirus patients will be pushing growth in the market for ventilators during the coming years.

Invasive Ventilators, followed by Non Invasive, and Hospitals attained substantial market share under Interface and End User segment respectively, chiefly on the back of burgeoning demand for ventilators from hospitals which are engaged in treating COVID19 patients. Further, companies from different industries entering the ventilators market in order to meet the unprecedented demand for ventilators coupled with government partnering up with manufacturers to provide ventilators to hospitals and healthcare units has been forecasted to supplement the market growth in the coming years.
Among the regions, North America, followed by Europe and Asia Pacific, will experience remarkable market share owing to presence of various leading global manufacturers in the region with companies ramping up their production capacity and sky rocketing number of coronavirus patients in United States supported by investment in expanding product portfolio by manufacturers to offer various types of ventilators to users, will facilitate market growth during the forecast period.

Scope of the Report

• The report analyses Ventilators market By Value.
• The report analyses Ventilators Market By Mobility (Intensive Care, Portable).
• The report further assesses the Ventilators market By Modes (Pressure, Volume, Combined, Others), By Interface (Invasive, and Non-Invasive), By End User (Hospitals, Ambulatory Surgical Centers, Home Care, Others).
• The Global Ventilators Market has been analysed By Region (North America, Europe, and Asia Pacific) and By Country (United States, Canada, Germany, France, United Kingdom, Italy, China, Japan, India, and South Korea).
• The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, Mobility Type, Interface Type, Mode Type, and End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The companies analysed in the report include Philips Healthcare, ResMed, Medtronic, Becton, Dickinson and Company, Getinge, Dräger, Smiths Group, GE Healthcare, Fisher & Paykel, Vyaire Medical Inc.
• The report presents the analysis of Ventilators market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience

• Ventilators Manufacturers
• Medical Equipment Manufacturers
• Hospitals, Clinics, and Healthcare Units
• Consulting and Advisory Firms
• Investment Banks and Equity Firms

Table of Contents

1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary

2. Strategic Recommendations

3. Ventilator Market: Product Outlook

4. Global Ventilator Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025

5. Global Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User
5.1 Competitive Scenario of Global Ventilator Market: By Mobility
5.1.1 Intensive Care – Market Size and Forecast (2015-2025)
5.1.2 Portable – Market Size and Forecast (2015-2025)
5.2 Competitive Scenario of Global Ventilator Market: By Modes
5.2.1 Pressure – Market Size and Forecast (2015-2025)
5.2.2 Volume – Market Size and Forecast (2015-2025)
5.2.3 Combined – Market Size and Forecast (2015-2025)
5.2.4 Others – Market Size and Forecast (2015-2025)
5.3 Competitive Scenario of Global Ventilator Market: By Interface
5.3.1 Invasive – Market Size and Forecast (2015-2025)
5.3.2 Non-Invasive – Market Size and Forecast (2015-2025)
5.4 Competitive Scenario of Global Ventilator Market : By End User
5.4.1 Hospitals – Market Size and Forecast (2015-2025)
5.4.2 Ambulatory Surgical Centers – Market Size and Forecast (2015-2025)
5.4.3 Home Care – Market Size and Forecast (2015-2025)
5.4.4 Others – Market Size and Forecast (2015-2025)

6. Global Ventilator Market: Regional Analysis
6.1 Competitive Scenario of Global Ventilator Market: By Region

7. North America Ventilator Market: An Analysis (2015-2025)
7.1 North America Ventilator Market: Size and Forecast (2015-2025), By Value
7.2 North America Ventilator Market – Prominent Companies
7.3 Market Segmentation By Mobility (Intensive Care, and Portable)
7.4 Market Segmentation By Modes (Pressure, Volume, Combined and Others)
7.5 Market Segmentation By Interface (Invasive, and Non-Invasive)
7.6 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Home Care and Others)

7.7 North America Ventilator Market: Country Analysis
7.8 Market Opportunity Chart of North America Ventilator Market – By Country, By Value, 2025
7.9 Competitive Scenario of North America Ventilator Market: By Country
7.10 United States Ventilator Market: Size and Forecast (2015-2025), By Value
7.11 United States Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
7.12 Canada Ventilator Market: Size and Forecast (2015-2025), By Value
7.13 Canada Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)

8. Europe Ventilator Market: An Analysis (2015-2025)
8.1 Europe Ventilator Market: Size and Forecast (2015-2025), By Value
8.2 Europe Ventilator Market – Prominent Companies
8.3 Market Segmentation By Mobility (Intensive Care, and Portable)
8.4 Market Segmentation By Modes (Pressure, Volume, Combined and Others)
8.5 Market Segmentation By Interface (Invasive, and Non-Invasive)
8.6 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Home Care and Others)

8.7 Europe Ventilator Market: Country Analysis
8.8 Market Opportunity Chart of Europe Ventilator Market – By Country, By Value, 2025
8.9 Competitive Scenario of Europe Ventilator Market : By Country
8.10 Germany Ventilator Market: Size and Forecast (2015-2025), By Value
8.11 Germany Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
8.12 France Ventilator Market: Size and Forecast (2015-2025), By Value
8.13 France Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
8.14 United Kingdom Ventilator Market: Size and Forecast (2015-2025), By Value
8.15 United Kingdom Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
8.16 Italy Ventilator Market: Size and Forecast (2015-2025), By Value
8.17 Italy Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)

9. Asia Pacific Ventilator Market: An Analysis (2015-2025)
9.1 Asia Pacific Ventilator Market: Size and Forecast (2015-2025), By Value
9.2 Asia Pacific Ventilator Market – Prominent Companies
9.3 Market Segmentation By Mobility (Intensive Care, and Portable)
9.4 Market Segmentation By Modes (Pressure, Volume, Combined and Others)
9.5 Market Segmentation By Interface (Invasive, and Non-Invasive)
9.6 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, Home Care and Others)

9.7 Asia Pacific Ventilator Market: Country Analysis
9.8 Market Opportunity Chart of Asia Pacific Ventilator Market – By Country, By Value, 2025
9.9 Competitive Scenario of Asia Pacific Ventilator Market : By Country
9.10 China Ventilator Market: Size and Forecast (2015-2025), By Value
9.11 China Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
9.12 Japan Ventilator Market: Size and Forecast (2015-2025), By Value
9.13 Japan Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
9.14 India Ventilator Market: Size and Forecast (2015-2025), By Value
9.15 India Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)
9.16 South Korea Ventilator Market: Size and Forecast (2015-2025), By Value
9.17 South Korea Ventilator Market Segmentation – By Mobility, By Modes, By Interface, and By End User (2015-2025)

10. Global Ventilator Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Ventilator Market – By Mobility, 2025
11.2 Market Attractiveness Chart of Global Ventilator Market – By Modes, 2025
11.3 Market Attractiveness Chart of Global Ventilator Market – By Interface, 2025
11.4 Market Attractiveness Chart of Global Ventilator Market – By End User, 2025
11.5 Market Attractiveness Chart of Global Ventilator Market – By Region, 2025

12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers During COVID
12.2 Market Share Analysis

13. Company Analysis (Business Description, Financial Analysis, Business Strategy)
13.1 Philips Healthcare
13.2 ResMed
13.3 Medtronic
13.4 Becton, Dickinson and Company
13.5 Getinge
13.6 Dräger
13.7 Smiths Group
13.8 GE Healthcare
13.9 Fisher & Paykel
13.10 Vyaire Medical Inc.

List of Figures

Figure 1: Global Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Global Ventilator Market, By Months, 2020 (In USD Millions)
Figure 3: Global Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 4: Global Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 5: Global Prevalence of Stroke, 2014-2017 (In Millions)
Figure 6: Global Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 7: Global Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 8: Global Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 9: Global Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 10: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 11: Global Number of Intensive Care Beds, 2020 (In Numbers)
Figure 12: Global Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 13: Global Ventilator Market, By Mobility, 2019, 2025
Figure 14: Global Ventilator Market – By Intensive Care, By Value (USD Million), 2015-2025
Figure 15: Global Ventilator Market – By Portable, By Value (USD Million), 2015-2025
Figure 16: Global Ventilator Market, By Modes, 2019, 2025
Figure 17: Global Ventilator Market – By Pressure, By Value (USD Million), 2015-2025
Figure 18: Global Ventilator Market – By Volume, By Value (USD Million), 2015-2025
Figure 19: Global Ventilator Market – By Combined, By Value (USD Million), 2015-2025
Figure 20: Global Ventilator Market – By Others, By Value (USD Million), 2015-2025
Figure 21: Global Ventilator Market, By Interface, 2019, 2025
Figure 22: Global Ventilator Market – By Invasive, By Value (USD Million), 2015-2025
Figure 23: Global Ventilator Market – By Non Invasive, By Value (USD Million), 2015-2025
Figure 24: Global Ventilator Market, By End User, 2019, 2025
Figure 25: Global Ventilator Market – By Hospitals, By Value (USD Million), 2015-2025
Figure 26: Global Ventilator Market – By Ambulatory Surgical Centers, By Value (USD Million), 2015-2025
Figure 27: Global Ventilator Market – By Home Care, By Value (USD Million), 2015-2025
Figure 28: Global Ventilator Market – By Others, By Value (USD Million), 2015-2025
Figure 29: Global Ventilator Market, By Region, 2019, 2025
Figure 30: North America Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 31: North America Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 32: North America Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 33: North America Prevalence of Stroke, 2014-2017 (In Millions)
Figure 34: North America Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 35: North America Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 36: North America Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 37: North America Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 38: North America Number of Intensive Care Beds, 2020 (In Numbers)
Figure 39: North America Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 40: North America Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 41: North America Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 42: North America Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 43: North America Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 44: Market Opportunity Chart of North America Ventilator Market – By Country, By Value, 2025
Figure 45: North America Ventilator Market, By Country, 2019, 2025
Figure 46: United States Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 47: United States Projected Need for Non-Invasive Ventilators (In 1000)
Figure 48: United States Projected Need for Invasive Ventilators (In 1000)
Figure 49: United States Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 50: United States Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 51: United States Prevalence of Stroke, 2014-2017 (In Millions)
Figure 52: United States Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 53: United States Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 54: United States Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 55: United States Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 56: United States Average Income and Expenditures of All Consumer Units, 2017, 2018 (In %)
Figure 57: United States Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 58: United States Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 59: United States Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 60: United States Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 61: Canada Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 62: Canada Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 63: Canada Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 64: Canada Prevalence of Stroke, 2014-2017 (In Millions)
Figure 65: Canada Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 66: Canada Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 67: Canada Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 68: Canada Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 69: Canada Average Income and Expenditures Per Household, 2017, 2018 (In %)
Figure 70: Canada Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 71: Canada Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 72: Canada Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 73: Canada Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 74: Europe Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 75: Europe Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 76: Europe Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Millions)
Figure 77: Europe Prevalence of Stroke, 2014-2017 (In Millions)
Figure 78: Europe Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 79: Europe Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 80: Europe Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 81: Europe Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 82: European Union Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 83: Europe Number of Intensive Care Beds, 2020 (In Numbers)
Figure 84: Europe Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 85: Europe Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 86: Europe Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 87: Europe Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 88: Europe Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 89: Market Opportunity Chart of Europe Ventilator Market – By Country, By Value, 2025
Figure 90: Europe Ventilator Market, By Country, 2019, 2025
Figure 91: Germany Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 92: Germany Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 93: Germany Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 94: Germany Prevalence of Stroke, 2014-2017 (In Millions)
Figure 95: Germany Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 96: Germany Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 97: Germany Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 98: Germany Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 99: Germany Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 100: Germany Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 101: Germany Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 102: Germany Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 103: Germany Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 104: France Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 105: France Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 106: France Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 107: France Prevalence of Stroke, 2014-2017 (In Millions)
Figure 108: France Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 109: France Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 110: France Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 111: France Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 112: France Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 113: France Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 114: France Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 115: France Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 116: France Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 117: United Kingdom Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 118: United Kingdom Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 119: United Kingdom Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 120: United Kingdom Prevalence of Stroke, 2014-2017 (In Millions)
Figure 121: United Kingdom Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 122: United Kingdom Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 123: United Kingdom Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 124: United Kingdom Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 125: United Kingdom Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 126: United Kingdom Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 127: United Kingdom Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 128: United Kingdom Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 129: United Kingdom Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 130: Italy Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 131: Italy Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 132: Italy Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 133: Italy Prevalence of Stroke, 2014-2017 (In Millions)
Figure 134: Italy Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 135: Italy Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 136: Italy Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 137: Italy Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 138: Italy Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 139: Italy Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 140: Italy Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 141: Italy Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 142: Italy Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 143: Asia Pacific Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 144: Asia Pacific Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 145: Asia Pacific Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 146: Asia Pacific Prevalence of Stroke, 2014-2017 (In Millions)
Figure 147: Asia Pacific Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 148: Asia Pacific Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 149: Asia Pacific Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 150: Asia Pacific Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 151: Asia Pacific Number of Intensive Care Beds, 2020 (In Numbers)
Figure 152: Asia Pacific Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 153: Asia Pacific Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 154: Asia Pacific Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 155: Asia Pacific Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 156: Asia Pacific Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 157: Market Opportunity Chart of Asia Pacific Ventilator Market – By Country, By Value, 2025
Figure 158: Asia Pacific Ventilator Market, By Country, 2019, 2025
Figure 159: China Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 160: China Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 161: China Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 162: China Prevalence of Stroke, 2014-2017 (In Millions)
Figure 163: China Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 164: China Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 165: China Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 166: China Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 167: China Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 168: China Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 169: China Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 170: China Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 171: Japan Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 172: Japan Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 173: Japan Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 174: Japan Prevalence of Stroke, 2014-2017 (In Millions)
Figure 175: Japan Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 176: Japan Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 177: Japan Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 178: Japan Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 179: Japan Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 180: Japan Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 181: Japan Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 182: Japan Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 183: India Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 184: India Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 185: India Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 186: India Prevalence of Stroke, 2014-2017 (In Millions)
Figure 187: India Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 188: India Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 189: India Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 190: India Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 191: India Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 192: India Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 193: India Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 194: India Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 195: South Korea Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 196: South Korea Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 197: South Korea Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 198: South Korea Prevalence of Stroke, 2014-2017 (In Millions)
Figure 199: South Korea Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 200: South Korea Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 201: South Korea Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 202: South Korea Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 203: South Korea Ventilator Market – By Mobility, By Value, 2015-2025 (USD Million)
Figure 204: South Korea Ventilator Market – By Modes, By Value, 2015-2025 (USD Million)
Figure 205: South Korea Ventilator Market – By Interface, By Value, 2015-2025 (USD Million)
Figure 206: South Korea Ventilator Market – By End User, By Value, 2015-2025 (USD Million)
Figure 207: Market Attractiveness Chart of Global Ventilator Market – By Mobility, 2025
Figure 208: Market Attractiveness Chart of Global Ventilator Market – By Modes, 2025
Figure 209: Market Attractiveness Chart of Global Ventilator Market – By Interface, 2025
Figure 210: Market Attractiveness Chart of Global Ventilator Market – By End User, 2025
Figure 211: Market Attractiveness Chart of Global Ventilator Market – By Region, 2025
Figure 212: Market Share of Leading Global Ventilator Companies, 2019 (In %)
Figure 213: Philips Group Revenue, 2015-2019 (In USD Billion)
Figure 214: Philips Group Revenue, By Business Segment, 2018 (In %)
Figure 215: Philips Group Revenue, By Business Segment, 2019 (In %)
Figure 216: Philips Group Revenue, By Diagnosis & Treatment, 2019 (In %)
Figure 217: Philips Group Revenue, By Connected Care, 2019 (In %)
Figure 218: Philips Group Revenue, By Personal Health, 2019 (In %)
Figure 219: Philips Group Revenue, By Countries, 2018 (In %)
Figure 220: Philips Group Revenue, By Countries, 2019 (In %)
Figure 221: Philips Group Revenue, By Countries, 2018 (In %)
Figure 222: Philips Group Revenue, By Countries, 2019 (In %)
Figure 223: ResMed Revenue, 2015-2019 (In USD Billion)
Figure 224: ResMed Net Revenue, By Business Segment, 2018 (In %)
Figure 225: ResMed Net Revenue, By Business Segment, 2019 (In %)
Figure 226: ResMed Net Revenue, By Region, 2018 (In %)
Figure 227: ResMed Net Revenue, By Region, 2019 (In %)
Figure 228: Medtronic Revenue, 2015-2019 (In USD Billion)
Figure 229: Medtronic Net Sales, By Region, 2018 (In %)
Figure 230: Medtronic Net Sales, By Region, 2019 (In %)
Figure 231: Medtronic Net Sales, By Business Segment, By Region, 2018 (In USD Million)
Figure 232: Medtronic Net Sales, By Business Segment, 2018 (In %)
Figure 233: Medtronic Net Sales, By Business Segment, 2019 (In %)
Figure 234: Becton, Dickinson and Company Revenue, 2015-2019 (In USD Billion)
Figure 235: Becton, Dickinson and Company Net Sales, By Business Segment, 2018 (In %)
Figure 236: Becton, Dickinson and Company Net Sales, By Business Segment, 2019 (In %)
Figure 237: Becton, Dickinson and Company Net Sales, By Geographical Region, 2018 (In %)
Figure 238: Becton, Dickinson and Company Net Sales, By Geographical Region, 2019 (In %)
Figure 239: Getinge Revenue, 2015-2019 (In USD Billion)
Figure 240: Getinge Net Sales, By Business Segment, 2018 (In %)
Figure 241: Getinge Net Sales, By Business Segment, 2019 (In %)
Figure 242: Getinge Net Sales, By Geographical Region, 2018 (In %)
Figure 243: Getinge Net Sales, By Geographical Region, 2019 (In %)
Figure 244: Drager Revenue, 2015-2019 (In USD Billion)
Figure 245: Drager Net Sales, By Business Segment, 2018 (In %)
Figure 246: Drager Net Sales, By Business Segment, 2019 (In %)
Figure 247: Drager Net Sales, By Geographical Region, 2018 (In %)
Figure 248: Drager Net Sales, By Geographical Region, 2019 (In %)
Figure 249: Smiths Group Revenue, 2015-2019 (In USD Billion)
Figure 250: Smiths Group Net Sales, By Market, 2018 (In %)
Figure 251: Smiths Group Net Sales, By Market, 2019 (In %)
Figure 252: Smiths Group Net Sales, By Business Division, 2018 (In %)
Figure 253: Smiths Group Net Sales, By Business Division, 2019 (In %)
Figure 254: Smiths Group Net Sales, By Regions, 2017 (In %)
Figure 255: Smiths Group Net Sales, By Regions, 2018 (In %)
Figure 256: GE Revenue, 2015-2019 (In USD Billion)
Figure 257: GE Net Sales, By Business Segment, 2018 (In %)
Figure 258: GE Net Sales, By Business Segment, 2019 (In %)
Figure 259: GE Net Sales, By Geographical Region, 2018 (In %)
Figure 260: GE Net Sales, By Geographical Region, 2019 (In %)
Figure 261: Fisher & Paykel Revenue, 2015-2019 (In USD Million)
Figure 262: Fisher & Paykel Net Sales, By Business Segment, 2018 (In %)
Figure 263: Fisher & Paykel Net Sales, By Business Segment, 2019 (In %)
Figure 264: Fisher & Paykel Net Sales, By Geographical Region, 2018 (In %)
Figure 265: Fisher & Paykel Net Sales, By Geographical Region, 2019 (In %)

Choose License Type

Single user
$2,400
Enterprise User
$3,000
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.